caketin:
Disagree with your comment of AHZ being a ".......agonisingly slowly dying dog..."
Don't be surprised if there if there is a second/third - quarter announcement of a partnership with a global company, provided the due - diligence stacks up.
And don't expect to hear from WP as often as we did in the past. He will be much more measured.
As I posted previously, we should accept AHZ is in essence a start - up - company and will have its ups and downs, akin to Avita Medical (AVH) which I have held since its Clinical Cell Culture days at 7.5 cents and today is at 19 cents and rising.
From what I know about AHZ it will follow a similar path and that's why AHZ and AVH are my only two biomed companies.
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-206
-
- There are more pages in this discussion • 362 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |